English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915384      Online Users : 1302
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [327/330]
    Books/Book Section [1/1]
    Conference Papers/Meeting Abstract [115/179]

    Community Statistics


    Item counts issued in 3 years:74(14.51%)
    Items With Fulltext:443(86.86%)

    Download counts of the item
    Download times greater than 0:443(100.00%)
    Download times greater than 100:426(96.16%)
    Total Bitstream Download Counts:178127(3.32%)

    Last Update: 2024-12-01 08:26

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 121-130 of 510. (51 Page(s) Totally)
    << < 8 9 10 11 12 13 14 15 16 17 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2020-04 Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours British Journal of Cancer. 2020 Apr;122(9):1324-1332.
    2020-03 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO Annals of Oncology. 2020 Mar;31(3):334-351.
    2020-02 Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Cancer Science. 2020 Feb;111(2):513-527.
    2020-02 Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 477.
    2020-02 A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 383.
    2020-01 Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Gastric Cancer. 2020 Jan;23(1):143-153.
    2020-01 Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer [Erraturm: Oncogene. 2016 May;35(12):1517-1528.] Oncogene. 2020 Jan;39(4):946-949.
    2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study European Journal of Cancer. 2020 Jan;124:123-130.
    2020-01 Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial Pancreas. 2020 Jan;49(1):62-75.
    2019-12 Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.

    Showing items 121-130 of 510. (51 Page(s) Totally)
    << < 8 9 10 11 12 13 14 15 16 17 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback